comparemela.com

StockNews.com upgraded shares of CEL-SCI (NYSEAMERICAN:CVM – Free Report) from a sell rating to a hold rating in a research report released on Tuesday. Separately, EF Hutton Acquisition Co. I restated a buy rating and issued a $10.00 price objective on shares of CEL-SCI in a report on Thursday, March 9th. CEL-SCI Price Performance Shares […]

Related Keywords

,Nations Financial Group Inc ,Company Profile ,Ef Hutton Acquisition Co ,Investors Services ,Free Report ,Sigma Investments ,Nations Financial Group ,Leukocyte Interleukin ,Cel Sci ,Nyseamerican Cvm ,Icvm ,Medical ,Upgrade ,Stocknews Com ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.